Location History:
- DK-2700 Bronshoj, DK (2005)
- Bronshoj, DK (2008 - 2011)
Company Filing History:
2 out of 1,778 
2 out of 832,961 Years Active: 2005-2011
Title: Soren Ostergaard: Innovator in Insulin and NCAM Binding Compounds
Introduction
Soren Ostergaard is a notable inventor based in Bronshoj, Denmark. He has made significant contributions to the field of biochemistry, particularly in the development of novel ligands for insulin hexamers and compounds related to the neural cell adhesion molecule (NCAM). With a total of 4 patents, his work has the potential to impact medical treatments and therapies.
Latest Patents
Ostergaard's latest patents include innovative ligands for the HisZnsites of the R-state insulin hexamer. These ligands have a specific formula, A-B-C-D-X, where A is a chemical group that binds reversibly to the HisZnsites of an insulin hexamer, B is a linker, C consists of neutral amino acids, D comprises positively charged groups, and X can be a hydroxyl, amino, or diamino group. Additionally, he has developed NCAM binding compounds that stimulate the proliferation and outgrowth of cells presenting the NCAM. These inventions hold promise for treating normal, degenerated, and damaged NCAM presenting cells.
Career Highlights
Throughout his career, Soren Ostergaard has worked with prominent companies, including Novo Nordisk A/S. His expertise in biochemistry and innovative thinking has led to advancements in insulin therapies and cell adhesion research.
Collaborations
Ostergaard has collaborated with notable professionals in his field, including Lars Christian Ronn and Arne Holm. These partnerships have contributed to the success of his research and inventions.
Conclusion
Soren Ostergaard's contributions to the fields of insulin and NCAM binding compounds demonstrate his innovative spirit and dedication to advancing medical science. His patents reflect a commitment to improving therapeutic options for patients.